晚期多病的描述:范围综述和内容分析。

Journal of multimorbidity and comorbidity Pub Date : 2025-03-18 eCollection Date: 2025-01-01 DOI:10.1177/26335565251326309
Sarah P Bowers, Polly Black, Lewis McCheyne, Darcy Wilson, Rose S Penfold, Liam Stapleton, Pam Channer, Sarah E E Mills, Linda Williams, Frances Quirk, Jo Bowden
{"title":"晚期多病的描述:范围综述和内容分析。","authors":"Sarah P Bowers, Polly Black, Lewis McCheyne, Darcy Wilson, Rose S Penfold, Liam Stapleton, Pam Channer, Sarah E E Mills, Linda Williams, Frances Quirk, Jo Bowden","doi":"10.1177/26335565251326309","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Multimorbidity is associated with adverse clinical outcomes, including increased symptom burden and healthcare utilisation, particularly towards the end of life. Despite this, there is no accepted method to identify the point at which individuals with deteriorating health due to long-term conditions are nearing the end of life or might benefit from a palliative care approach - conceptualised as 'Advanced Multimorbidity'. This scoping review explored how Advanced Multimorbidity is described and operationalised within the literature.</p><p><strong>Methods: </strong>Multiple electronic databases and Grey Literature sources were searched following scoping review frameworks. Two reviewers independently performed screening and data extraction. Content analysis was used to examine the different descriptions of Advanced Multimorbidity. Stakeholder consultations were undertaken with clinicians, academics and public participants. Patient and public involvement was separately integrated throughout this review from conceptualisation, design and reporting.</p><p><strong>Results: </strong>Forty-four different descriptions of Advanced Multimorbidity were identified from 38 publications. These varied in terms of the clinical conditions and descriptors used. Eighteen descriptions relied on a single indicator to identify Advanced Multimorbidity; 24 used a multidimensional approach. Stakeholder consultations highlighted the need for descriptions that are user-friendly and actionable.</p><p><strong>Conclusion: </strong>The lack of a standardised definition of Advanced Multimorbidity risks variance in clinical and research practice, potentially affecting patient care. A consensus on defining Advanced Multimorbidity would enable better identification of patients who could benefit from a palliative care approach, ensuring more consistent and person-centred care, as well as supporting research and policy development.</p>","PeriodicalId":73843,"journal":{"name":"Journal of multimorbidity and comorbidity","volume":"15 ","pages":"26335565251326309"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11920996/pdf/","citationCount":"0","resultStr":"{\"title\":\"Descriptions of advanced multimorbidity: A scoping review with content analysis.\",\"authors\":\"Sarah P Bowers, Polly Black, Lewis McCheyne, Darcy Wilson, Rose S Penfold, Liam Stapleton, Pam Channer, Sarah E E Mills, Linda Williams, Frances Quirk, Jo Bowden\",\"doi\":\"10.1177/26335565251326309\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Multimorbidity is associated with adverse clinical outcomes, including increased symptom burden and healthcare utilisation, particularly towards the end of life. Despite this, there is no accepted method to identify the point at which individuals with deteriorating health due to long-term conditions are nearing the end of life or might benefit from a palliative care approach - conceptualised as 'Advanced Multimorbidity'. This scoping review explored how Advanced Multimorbidity is described and operationalised within the literature.</p><p><strong>Methods: </strong>Multiple electronic databases and Grey Literature sources were searched following scoping review frameworks. Two reviewers independently performed screening and data extraction. Content analysis was used to examine the different descriptions of Advanced Multimorbidity. Stakeholder consultations were undertaken with clinicians, academics and public participants. Patient and public involvement was separately integrated throughout this review from conceptualisation, design and reporting.</p><p><strong>Results: </strong>Forty-four different descriptions of Advanced Multimorbidity were identified from 38 publications. These varied in terms of the clinical conditions and descriptors used. Eighteen descriptions relied on a single indicator to identify Advanced Multimorbidity; 24 used a multidimensional approach. Stakeholder consultations highlighted the need for descriptions that are user-friendly and actionable.</p><p><strong>Conclusion: </strong>The lack of a standardised definition of Advanced Multimorbidity risks variance in clinical and research practice, potentially affecting patient care. A consensus on defining Advanced Multimorbidity would enable better identification of patients who could benefit from a palliative care approach, ensuring more consistent and person-centred care, as well as supporting research and policy development.</p>\",\"PeriodicalId\":73843,\"journal\":{\"name\":\"Journal of multimorbidity and comorbidity\",\"volume\":\"15 \",\"pages\":\"26335565251326309\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11920996/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of multimorbidity and comorbidity\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/26335565251326309\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of multimorbidity and comorbidity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26335565251326309","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

简介:多病与不良临床结果相关,包括症状负担增加和医疗保健利用,特别是在生命末期。尽管如此,目前还没有公认的方法来确定由于长期疾病而导致健康状况恶化的个体接近生命终点或可能受益于姑息治疗方法的点-概念化为“晚期多病”。这篇综述探讨了如何在文献中描述和操作晚期多病。方法:根据范围审查框架检索多个电子数据库和灰色文献来源。两名审稿人独立进行筛选和数据提取。内容分析用于检查晚期多重疾病的不同描述。与临床医生、学者和公众参与者进行了利益攸关方磋商。患者和公众的参与分别从概念化、设计和报告中纳入整个审查。结果:从38篇出版物中鉴定出44种不同的晚期多病描述。这些在临床条件和使用的描述符方面有所不同。18种描述依赖于单一指标来识别晚期多病;24采用了多维方法。利益攸关方磋商强调了对用户友好和可操作的描述的必要性。结论:在临床和研究实践中缺乏对晚期多病风险差异的标准化定义,可能影响患者护理。就晚期多病的定义达成共识,将有助于更好地识别可能受益于姑息治疗方法的患者,确保更加一致和以人为本的护理,并支持研究和政策制定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Descriptions of advanced multimorbidity: A scoping review with content analysis.

Introduction: Multimorbidity is associated with adverse clinical outcomes, including increased symptom burden and healthcare utilisation, particularly towards the end of life. Despite this, there is no accepted method to identify the point at which individuals with deteriorating health due to long-term conditions are nearing the end of life or might benefit from a palliative care approach - conceptualised as 'Advanced Multimorbidity'. This scoping review explored how Advanced Multimorbidity is described and operationalised within the literature.

Methods: Multiple electronic databases and Grey Literature sources were searched following scoping review frameworks. Two reviewers independently performed screening and data extraction. Content analysis was used to examine the different descriptions of Advanced Multimorbidity. Stakeholder consultations were undertaken with clinicians, academics and public participants. Patient and public involvement was separately integrated throughout this review from conceptualisation, design and reporting.

Results: Forty-four different descriptions of Advanced Multimorbidity were identified from 38 publications. These varied in terms of the clinical conditions and descriptors used. Eighteen descriptions relied on a single indicator to identify Advanced Multimorbidity; 24 used a multidimensional approach. Stakeholder consultations highlighted the need for descriptions that are user-friendly and actionable.

Conclusion: The lack of a standardised definition of Advanced Multimorbidity risks variance in clinical and research practice, potentially affecting patient care. A consensus on defining Advanced Multimorbidity would enable better identification of patients who could benefit from a palliative care approach, ensuring more consistent and person-centred care, as well as supporting research and policy development.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信